Erika F. Helmuth Saunders

Erika F. Helmuth Saunders

Auto-generated profile, based on publicly available information

Erika F. Helmuth Saunders

Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Frontiers in Neuroendocrinology
Verified
Journal Article
Closed access
MMMarzieh Majd
Marzieh Majd
ESErika F.H. Saunders
Erika F.H. Saunders
CEChristopher Gerald Engeland
Christopher Gerald Engeland

1 April 2014 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
AFAndrew S. Fouche
Andrew S. Fouche
ESErika F.H. Saunders
Erika F.H. Saunders
Timothy CraigTimothy Craig
Timothy Craig

15 February 2019 in Circulation Research
Verified
Journal Article
Closed access
JGJody L. Greaney
Jody L. Greaney
ESErika F.H. Saunders
Erika F.H. Saunders
LSLakshmi Santhanam
Lakshmi Santhanam
LALacy M. Alexander
Lacy M. Alexander
Rationale:: In rodent models of depression, oxidative stress-induced reductions in NO bioavailability contribute to impaired endothelium-dependent dilation. Endothelial dysfunction is evident in major depressive disorder (MDD); however, the molecular mediators remain undefined. Objective:: We sought to translate preclinical findings to humans by testing the role of oxidative stress in mediating microvascular endothelial dysfunction, including potential modulatory influences of sex, in MDD. Methods and Results:: Twenty-four treatment-naive, otherwise healthy, young adults with MDD (14 women; 18–23 years) and 20 healthy adults (10 women; 19–30 years) participated. Red blood cell flux (laser Doppler flowmetry) was measured during graded intradermal microdialysis perfusion of the endothelium-dependent agonist acetylcholine, alone and in combination with an NO synthase inhibitor (L-NAME), a superoxide scavenger (Tempol), and an NADPH oxidase inhibitor (apocynin), as well as during perfusion of the endothelium-independent agonist sodium nitroprusside. Tissue oxidative stress markers (eg, nitrotyrosine abundance, superoxide production) were also quantified. Endothelium-dependent dilation was blunted in MDD and mediated by reductions in NO-dependent dilation. Endothelium-independent dilation was likewise attenuated in MDD. In MDD, there were no sex differences in either NO-mediated endothelium-dependent dilation or endothelium-independent dilation. Acute scavenging of superoxide or inhibition of NADPH oxidase improved NO-dependent dilation in MDD. Expression and activity of oxidative stress markers were increased in MDD. In a subset of adults with MDD treated with a selective serotonin reuptake inhibitor for their depressive symptoms and in remission (n=8; 7 women; 19–37 years), NO-mediated endothelium-dependent dilation was preserved, but endothelium-independent dilation was impaired, compared with healthy adults. Conclusions:: Oxidative stress-induced reductions in NO-dependent dilation, as well as alterations in vascular smooth muscle function, directly contribute to microvascular dysfunction in MDD. Strategies targeting vascular oxidative stress may be viable therapeutic options for improving NO-mediated endothelial function and reducing cardiovascular risk in MDD.

1 May 2010 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SLScott A. Langenecker
Scott A. Langenecker
ESErika F.H. Saunders
Erika F.H. Saunders
AKAllison M. Kade
Allison M. Kade
MRMichael T. Ransom
Michael T. Ransom
MMMelvin G. McInnis
Melvin G. McInnis


1 January 2016 in Psychiatry Research
Verified
Journal Article
Closed access
DMDavid F. Marshall
David F. Marshall
APAlessandra M. Passarotti
Alessandra M. Passarotti
KRKelly A. Ryan
Kelly A. Ryan
MKMasoud Kamali
Masoud Kamali
ESErika F.H. Saunders
Erika F.H. Saunders
SLScott A. Langenecker
Scott A. Langenecker